Nociceptive Sensitivity Research Articles

PACAP6-38 improves nitroglycerin-induced central sensitization by modulating synaptic plasticity at the trigeminal nucleus caudalis in a male rat model of chronic migraine

AimsChronic migraine (CM) is a common neurological disorder with complex pathogenesis. Evidence suggests that pituitary adenylate cyclase-activating peptide (PACAP) induces migraine-like attacks and may be potential a new target for migraine treatment, but the therapeutic results of targeting PACAP and its receptors are not uniform. Therefore, the aim of this study was to investigate the regulatory effect of PACAP type I receptor (PAC1R) antagonist, PACAP6-38, on nitroglycerin (NTG)-induced central sensitization in a CM model.MethodsSprague–Dawley (SD) rats received repeated injections of NTG to construct a CM model. Mechanical and thermal thresholds were measured using Von Frey filaments and hot plate tests. C-Fos expression was measured by western blotting and immunofluorescence staining to assess the central sensitization. PACAP6-38 was intracerebrally injected into the trigeminal nucleus caudalis (TNC), and then the changes in c-Fos, the synaptic-associated proteins, phospho-ERK1/2 (p-ERK1/2), phosphorylation of cyclic adenosine monophosphate response element-binding protein (p-CREB) and brain-derived neurotrophic factor (BDNF) were detected. Transmission electron microscopy (TEM) and Golgi-Cox staining were used to observe the ultrastructure of synapses and dendritic structures of TNC neurons.ResultsThe results showed that PACAP and PAC1R expression were significantly raised in the TNC after repeated NTG injections. Additionally, PACAP6-38 treatment alleviated nociceptive sensitization, inhibited NTG-induced overexpression of c-Fos and synaptic-associated proteins in the TNC of CM rat, restored aberrant synaptic structures. Furthermore, the expression of ERK/CREB/BDNF pathway was depressed by PACAP6-38.ConclusionsOur results demonstrated that abnormal synaptic structure in the TNC of CM, which could be reversed by inhibition of PAC1R via down-regulating the ERK/CREB/BDNF signaling pathway. PACAP6-38 improves NTG-induced central sensitization by regulating synaptic plasticity in the TNC of CM rat, which may provide new insights into the treatments targeting PACAP/PAC1R in migraine.

Effect of Voluntary Exercise on Endogenous Pain Control Systems and Post-traumatic Headache in Mice

Traumatic brain injury (TBI) can cause acute and chronic pain along with motor, cognitive, and emotional problems. Although the mechanisms are poorly understood, previous studies suggest disruptions in endogenous pain modulation may be involved. Voluntary exercise after a TBI has been shown to reduce some consequences of injury including cognitive impairment. We hypothesized, therefore, that voluntary exercise could augment endogenous pain control systems in a rodent model of TBI. For these studies, we used a closed-head impact procedure in male mice modeling mild TBI. We investigated the effect of voluntary exercise on TBI-induced hindpaw nociceptive sensitization, diffuse noxious inhibitory control failure, and periorbital sensitization after bright light stress, a model of post-traumatic headache. Furthermore, we investigated the effects of exercise on memory, circulating markers of brain injury, neuroinflammation, and spinal cord gene expression. We observed that exercise significantly reduced TBI-induced hindpaw allodynia and periorbital allodynia in the first week following TBI. We also showed that exercise improved the deficits associated with diffuse noxious inhibitory control and reduced bright light stress-induced allodynia up to 2 months after TBI. In addition, exercise preserved memory and reduced TBI-induced increases in spinal BDNF, CXCL1, CXCL2, and prodynorphin expression, all genes previously linked to TBI-induced nociceptive sensitization. Taken together, our observations suggest that voluntary exercise may reduce pain after TBI by reducing TBI-induced changes in nociceptive signaling and preserving endogenous pain control systems. PerspectiveThis article evaluates the effects of exercise on pain-related behaviors in a preclinical model of traumatic brain injury (TBI). The findings show that exercise reduces nociceptive sensitization, loss of diffuse noxious inhibitory control, memory deficits, and spinal nociception-related gene expression after TBI. Exercise may reduce or prevent pain after TBI.

The insulin receptor regulates the persistence of mechanical nociceptive sensitization in flies and mice.

Early phase diabetes is often accompanied by pain sensitization. In Drosophila, the insulin receptor (InR) regulates the persistence of injury-induced thermal nociceptive sensitization. Whether Drosophila InR also regulates the persistence of mechanical nociceptive sensitization remains unclear. Mice with a sensory neuron deletion of the insulin receptor (Insr) show normal nociceptive baselines; however, it is uncertain whether deletion of Insr in nociceptive sensory neurons leads to persistent nociceptive hypersensitivity. In this study, we used fly and mouse nociceptive sensitization models to address these questions. In flies, InR mutants and larvae with sensory neuron-specific expression of RNAi transgenes targeting InR exhibited persistent mechanical hypersensitivity. Mice with a specific deletion of the Insr gene in Nav1.8+ nociceptive sensory neurons showed nociceptive thermal and mechanical baselines similar to controls. In an inflammatory paradigm, however, these mutant mice showed persistent mechanical (but not thermal) hypersensitivity, particularly in female mice. Mice with the Nav1.8+ sensory neuron-specific deletion of Insr did not show metabolic abnormalities typical of a defect in systemic insulin signaling. Our results show that some aspects of the regulation of nociceptive hypersensitivity by the insulin receptor are shared between flies and mice and that this regulation is likely independent of metabolic effects.

ID: 218628 Downregulation of mTOR Signaling Pathway by Injecting rAAV-shmTOR to Alleviate Pain in SNI Model

The activation of mammalian target of rapamycin (mTOR), a serine/threonine protein kinase, has been known as one of the contributing factors in nociceptive sensitization after peripheral injury. Notably, its activation followed by the phosphorylation of downstream effectors causes the hyperexcitability of primary sensory neurons located in dorsal root ganglion (DRG). We investigated whether the inhibition of mTOR activation by directly injecting rAAV-shmTOR at the sciatic nerve of spared nerve injury (SNI) neuropathic pain model may decrease neuronal hyperexcitability in the DRG, along with downregulation of downstream effectors.

Biocompatible AlOOH-based memristor with biomimicking synaptic functions for artificial nociceptor applications

Electronic devices with biomimetic synaptic characteristics are one of the most critical components in health monitoring and artificial intelligence. The design of neuromorphic responsive devices, however, yet remains a ground challenge. Herein, a biocompatible and electrically responsive boehmite material (γ-AlOOH) is utilized to fabricate artificial memristors to realize mimicking biological synapsefunctions. The obtained AlOOH memristor is flexible, highly transparent, and biocompatible, exhibiting nonvolatile resistive switching behaviours with low threshold voltages, high ON-OFF ratios (>103), good switching durability (>104 cycles), and long retention time (>104 s). Specifically, the device can mimic the biosynaptic functions, such as paired-pulse facilitation (PPF), long-term potentiation/depression (LTP/LTD), amplitude-dependent plasticity (SADP), and spike time dependent plasticity (STDP), and the typical sensitization, desensitization, hyperalgesia, and allodynia behaviours of the biological nociceptors. This study reveals that the AlOOH memristor with excellent artificial synapses is resulted by the high proton mobility along with the OH bond length variation of AlOOH subjected to applied stimuli, such as voltages, pulse width, and pulse intervals. Therefore, the biocompatible AlOOH-based memristors with artificial synapse behaviour have promising potential for the applications in high-performance neuromorphic devices and future artificial intelligence.

Inflammation in pathogenesis of chronic pain: Foe and friend.

Chronic pain is a refractory health disease worldwide causing an enormous economic burden on individuals and society. Accumulating evidence suggests that inflammation in the peripheral nervous system (PNS) and central nervous system (CNS) is the major factor in the pathogenesis of chronic pain. The inflammation in the early- and late phase may have distinctive effects on the initiation and resolution of pain, which can be viewed as friend or foe. On the one hand, painful injuries lead to the activation of glial cells and immune cells in the PNS, releasing pro-inflammatory mediators, which contribute to the sensitization of nociceptors, leading to chronic pain; neuroinflammation in the CNS drives central sensitization and promotes the development of chronic pain. On the other hand, macrophages and glial cells of PNS and CNS promote pain resolution via anti-inflammatory mediators and specialized pro-resolving mediators (SPMs). In this review, we provide an overview of the current understanding of inflammation in the deterioration and resolution of pain. Further, we summarize a number of novel strategies that can be used to prevent and treat chronic pain by controlling inflammation. This comprehensive view of the relationship between inflammation and chronic pain and its specific mechanism will provide novel targets for the treatment of chronic pain.

Identification of key factors driving inflammation-induced sensitization of muscle sensory neurons.

Sensory neurons embedded in muscle tissue that initiate pain sensations, i.e., nociceptors, are temporarily sensitized by inflammatory mediators during musculoskeletal trauma. These neurons transduce peripheral noxious stimuli into an electrical signal [i.e., an action potential (AP)] and, when sensitized, demonstrate lower activation thresholds and a heightened AP response. We still do not understand the relative contributions of the various transmembrane proteins and intracellular signaling processes that drive the inflammation-induced hyperexcitability of nociceptors. In this study, we used computational analysis to identify key proteins that could regulate the inflammation-induced increase in the magnitude of AP firing in mechanosensitive muscle nociceptors. First, we extended a previously validated model of a mechanosensitive mouse muscle nociceptor to incorporate two inflammation-activated G protein-coupled receptor (GPCR) signaling pathways and validated the model simulations of inflammation-induced nociceptor sensitization using literature data. Then, by performing global sensitivity analyses that simulated thousands of inflammation-induced nociceptor sensitization scenarios, we identified three ion channels and four molecular processes (from the 17 modeled transmembrane proteins and 28 intracellular signaling components) as potential regulators of the inflammation-induced increase in AP firing in response to mechanical forces. Moreover, we found that simulating single knockouts of transient receptor potential ankyrin 1 (TRPA1) and reducing the rates of Gαq-coupled receptor phosphorylation and Gαq subunit activation considerably altered the excitability of nociceptors (i.e., each modification increased or decreased the inflammation-induced fold change in the number of triggered APs compared to when all channels were present). These results suggest that altering the expression of TRPA1 or the concentration of intracellular Gαq might regulate the inflammation-induced increase in AP response of mechanosensitive muscle nociceptors.

Effects of Post Trauma Morphine On Dorsal Horn Neuron Excitability: Studies using cFOS and RNAscope

Previous research has shown that a 5-day course of morphine enhances nociceptive sensitivity and allodynia when given 10 days after chronic constriction injury (CCI) as measured by the Von Frey test, a test where the hindpaw is poked with force (measured in grams) calibrated filament. This increased sensitivity to touch suggests that post trauma morphine makes second order sensory dorsal horn neurons more excitable. Therefore, it is hypothesized that during morphine enhanced allodynia, dorsal horn neurons will be more excitable to nociceptive stimulus. It was found that morphine enhanced allodynia causes more excitable neurons across a larger spatial range of the spinal cord, both rostral-caudal and dorsal-ventral along the dorsal horn. Mechanisms for the increased excitability of the dorsal horn are proposed and explored. These findings add to a robust literature which has detailed the paradoxical pain amplifying effects of morphine. Further, this study predicts that hyperexcitability of pain and touch pathways may occur as a clinically unintended side effect of morphine when administered to treat ongoing neuropathic pain. Lay Summary When working on the body, opioids take effect on various cells- including cells of the nervous system known as Glia. These glial cells produce various inflammatory responses that are typically known to decrease inflammation in the body. However, prior literature has revealed that following an activated state, these cells enter a “primed” form. If a second immunological activation occurs during this primed state, glial cells have been shown to release proteins that actually potentiate the state of pain. This study examines this hypothesis through the context of peripheral nerve injury (modeling injury, surgery, or trauma), followed by an administration of morphine. Using advanced imaging techniques, we are able to visualize exactly what modulators are inducing this potentiated pain response, as well as where in the nervous system these cells are found. Morphine has a potent effect on various aspects of the nervous system which may be alleviated by other treatment routes that focus specifically on the cell type and location that release the molecules that initiate the healing process. By unveiling the details of this mechanism, we can better understand how to treat patients following injury or surgery without inducing a higher pain response that can be caused by a short-term administration of morphine. To see the complete thesis, please visit https://scholar.colorado.edu/concern/undergraduate_honors_theses/0k225c53t.

Chronic Pelvic Pain Develops in Sensory Neuron Conditional Asic3 Null Mice Subjected to Chemical Injury

Sensitization of primary afferents is an important underlying mechanism for visceral hypersensitivity and pain. We investigated the contribution of acid-sensing ion channels (ASICs) in sensory neurons to the development of pain in a model of chemical-induced cystitis. ASICs are assembled as heterotrimers in bladder sensory neurons; however, the deletion of the ASIC3 subunit results in a loss-of-function phenotype with sensory neurons unable to discharge action potentials in response to acidification. In this study, conditional sensory neuron Asic3 knockout (KO) mice ( Asic3 fl/fl ;Avil-Cre +/- ) and control littermates ( Asic3 fl/fl ;Avil-Cre -/- ) received cyclophosphamide (CYP) (IP 80 mg/kg), or saline, every other day for five days. Experimental observations were made after one day (acute) or 14 days (chronic) after the last dose of CYP. In the acute setting, both control and conditional Asic3 KO mice treated with CYP exhibited an irritated bladder phenotype with a high number of voiding events of small volume. However, voiding activity normalized in both groups within two weeks of receiving CYP. In contrast, conditional Asic3 KO mice treated with CYP developed pelvic allodynia that persisted for at least two weeks, whereas control mice had no pain phenotype. In the chronic setting, no apparent edema or inflammatory cells were observed in bladders of control or conditional Asic3 KO mice, indicating that the pelvic allodynia seen in conditional Asic3 KO mice treated with CYP is likely driven by abnormal functioning of the nervous system and not by inflammation. To assess whether, in the chronic setting, the referred pelvic allodynia seen in conditional Asic3 KO mice treated with CYP is caused by sensitized primary afferents, we examined the firing evoked by sustained suprathreshold electrical stimulation of acutely isolated bladder sensory neurons. Sensory neurons were classified based of the sensitivity of the action potential to tetrodotoxin (TTX), as TTX-resistant (TTX-R) or TTX-sensitive (TTX-S). Strikingly, ~ 40% (11/17) of the bladder sensory neurons with TTX-R action potentials from conditional Asic3 KO mice treated with CYP exhibited aberrant firing (i.e., sensitization) in response to suprathreshold stimulation, compared to 3% (1/33) in control mice. These findings indicate that the pelvic allodynia seen in conditional Asic3 KO mice is driven in part by sensitized bladder afferents. Taken together, our studies support the notion that ASICs operate at the nerve terminals to modulate nociceptor excitability and sensitization. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Pain and Plasticity: Spike Sorting Based Approach for Characterizing the Neural Circuitry Mediating Nociceptive Sensitization of the Defensive Strike Response in M. sexta

Nociception is the neural process of encoding and processing noxious stimuli; this sensation is transduced by specialized sensory neurons called nociceptors. Activation of nociceptors typically evoke so called “nocifensive behavioral responses,” that are generally aimed at decreasing exposure to the noxious stimulus. Intense activation of nociceptors can result in long lasting changes in the nervous system, as well as a subsequent decrease in the threshold for perceiving and acting upon stimuli as if it were harmful—this persistent change in the organism is nociceptive sensitization. The hornworm, Manduca sexta, displays rapid defensive “striking” behavior that accurately targets the cite of noxious stimulation of the abdominal body wall. Nociceptive sensitization of the defensive strike response has been induced behaviorally and recapitulated in vitro through extracellular electrophysiology, where it appears to be encoded by an increase in the firing frequency occurring within the central nervous system, rather than changes in peripheral nociceptor signaling. The current model proposed by Tabuena et al. (2017), argues that central neural alterations are responsible for the neural correlate of nociceptive sensitization (Tabuena et al., 2017), rather than changes in spiking activity of the primary sensory neurons. While the changes in firing frequency centrally are undisputed, relegating sensitization to the CNS alone may be overly simplistic, as the model is based on the comparison of threshold crossings of purported multiunit activity, rather than of single cell activity of known populations of sensory and/or higher order neurons. Moreover, studies in the vertebrate and invertebrate literature alike have reported retrograde sensitization of primary nociceptors (Parada et al., 2003; Xie et al., 2022; Babcock et al., 2000), mediated by inflammatory signals from the cite of injury, thus complicating the question of central versus peripheral sensitization. Therefore, it is worth re-examining the possibility of presynaptic plasticity as an added contribution to nociceptive sensitization. In this work, we propose leveraging available neuroanatomical data to re-analyze the Tabuena et al. dataset, by performing spike sorting and spike train analyses to tease apart the signals originating from the peripheral sensory neurons to obtain input/output relationships between the identified sensory units and VNC spiking during stimulation. Distinguishing the nociceptor and tracking its stimulus dependent firing is expected to elucidate the contribution of nociceptor activity in nociceptive sensitization. Genentech Scholars Foundation This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis

Non-opioid targets are needed for addressing osteoarthritis pain, which is mechanical in nature and associated with daily activities such as walking and climbing stairs. Piezo2 has been implicated in the development of mechanical pain, but the mechanisms by which this occurs remain poorly understood, including the role of nociceptors. Here we show that nociceptor-specific Piezo2 conditional knock-out mice were protected from mechanical sensitization associated with inflammatory joint pain in female mice, joint pain associated with osteoarthritis in male mice, as well as both knee swelling and joint pain associated with repeated intra-articular injection of nerve growth factor in male mice. Single cell RNA sequencing of mouse lumbar dorsal root ganglia and in situ hybridization of mouse and human lumbar dorsal root ganglia revealed that a subset of nociceptors co-express Piezo2 and Ntrk1 (the gene that encodes the nerve growth factor receptor TrkA). These results suggest that nerve growth factor-mediated sensitization of joint nociceptors, which is critical for osteoarthritic pain, is also dependent on Piezo2, and targeting Piezo2 may represent a therapeutic option for osteoarthritis pain control.

Inflammation and subsequent nociceptor sensitization in the bone marrow are involved in an animal model of osteoarthritis pain

AimsThis study aimed to determine whether pathological changes in the bone marrow cause Osteoarthritis (OA) pain based on magnetic resonance imaging (MRI), immunohistochemistry, and electrophysiology. Main methodsAdjuvant-induced arthritis (AIA) was achieved by injecting 150 μL of complete Freund's adjuvant into the right knee joints of male Sprague-Dawley rats. AIA rats were compared with saline-injected rats. Key findingsAIA significantly induced mechanical hyperalgesia and spontaneous pain in the right hind paw 1–14 days after induction. Intratibial injection of 50 μL of 1 % lidocaine significantly suppressed AIA-induced mechanical hyperalgesia (p = 0.0001) and spontaneous pain (p = 0.0006) 3 days after induction. In T2-weighted MRI, AIA induced high-signal intensity within the proximal tibial metaphysis, and the mean T2 values in this area significantly increased on days 3 (p = 0.0043) and 14 (p = 0.0012) after induction. AIA induced intraosseous edema and significantly increased the number of intraosseous granulocytes on days 3 (p < 0.0001) and 14 (p < 0.0001) after induction. The electrophysiological study on days 3–7 after induction showed significantly increased spontaneous firing rates (p = 0.0166) and evoked responses to cutaneous stimuli (brush, p < 0.0001; pinching, p = 0.0359) in the right hind paw plantar surface and intratibial stimuli (p = 0.0002) in wide-dynamic-range neurons of the spinal dorsal horn. SignificanceIntraosseous changes caused by OA induce hypersensitivity in the sensory afferents innervating bone marrow may be involved in OA pain. Novel bone marrow-targeted therapies could be beneficial for treating OA pain.

Mild Traumatic Brain Injury-Induced Augmented Postsurgical Pain Is Driven by Central Serotonergic Pain-Facilitatory Signaling.

Individuals recovering from mild traumatic brain injury (mTBI) have increased rates of acute and chronic pain. However, the mechanism through which mTBI triggers heightened pain responses and the link between mTBI and postsurgical pain remain elusive. Recent data suggest that dysregulated serotonergic pain-modulating circuits could be involved. We hypothesized that mTBI triggers dysfunction in descending serotonergic pain modulation, which exacerbates acute pain and delays pain-related recovery after surgery. Using mouse models of mTBI and hindpaw incision for postsurgical pain in C57BL/6J mice, mechanical withdrawal thresholds were assessed throughout the postsurgical period. To determine whether mTBI leads to persistent alteration of endogenous opioid tone, mu-opioid receptors (MORs) were blocked with naloxone. Finally, the role of descending serotonergic signaling on postsurgical allodynia in animals with mTBI was examined using ondansetron (5-HT 3 receptor antagonist) or a serotonin-specific neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), to ablate descending serotonergic fibers. The treatment effects on withdrawal thresholds were normalized to baseline (percentage of maximum possible effect, MPE%), and analyzed using paired t -test or 2-way repeated-measures ANOVA with post hoc multiple comparisons. Post-mTBI mice demonstrated transient allodynia in hindpaws contralateral to mTBI, while no nociceptive changes were observed in sham-mTBI animals (mean difference, MD, MPE%, post-mTBI day 3: -60.9; 95% CI, -88.7 to -35.0; P < .001). After hindpaw incision, animals without mTBI exhibited transient allodynia, while mice with prior mTBI demonstrated prolonged postsurgical allodynia (MD-MPE% postsurgical day 14: -65.0; 95% CI, -125.4 to -4.5; P = .04). Blockade of MORs using naloxone transiently reinstated allodynia in mTBI animals but not in sham-mTBI mice (MD-MPE% post-naloxone: -69.9; 95% CI, -94.8 to -45.1; P < .001). Intrathecal administration of ondansetron reversed the allodynia observed post-mTBI and postincision in mTBI mice (compared to vehicle-treated mTBI mice, MD-MPE% post-mTBI day 3: 82.7; 95% CI, 58.5-106.9; P < .001; postsurgical day 17: 62.5; 95% CI, 38.3-86.7; P < .001). Both the acute allodynia after TBI and the period of prolonged allodynia after incision in mTBI mice were blocked by pretreatment with 5,7-DHT (compared to sham-mTBI mice, MD-MPE% post-mTBI day 3: 0.5; 95% CI, -18.5 to 19.5; P = .99; postsurgical day 14: -14.6; 95% CI, -16.7 to 45.9; P = .48). Similar behavioral patterns were observed in hindpaw ipsilateral to mTBI. Collectively, our results show that descending serotoninergic pain-facilitating signaling is responsible for nociceptive sensitization after mTBI and that central endogenous opioid tone opposes serotonin's effects. Understanding brain injury-related changes in endogenous pain modulation may lead to improved pain control for those with TBI undergoing surgery.

Celecoxib alleviates nociceptor sensitization mediated by interleukin-1beta-primed annulus fibrosus cells

PurposeThis study aims to analyze the effect of pro-inflammatory cytokine-stimulated human annulus fibrosus cells (hAFCs) on the sensitization of dorsal root ganglion (DRG) cells. We further hypothesized that celecoxib (cxb) could inhibit hAFCs-induced DRG sensitization.MethodshAFCs from spinal trauma patients were stimulated with TNF-α or IL-1β. Cxb was added on day 2. On day 4, the expression of pro-inflammatory and neurotrophic genes was evaluated using RT-qPCR. Levels of prostaglandin E2 (PGE-2), IL-8, and IL-6 were measured in the conditioned medium (CM) using ELISA. hAFCs CM was then applied to stimulate the DRG cell line (ND7/23) for 6 days. Then, calcium imaging (Fluo4) was performed to evaluate DRG cell sensitization. Both spontaneous and bradykinin-stimulated (0.5 μM) calcium responses were analyzed. The effects on primary bovine DRG cell culture were performed in parallel to the DRG cell line model.ResultsIL-1ß stimulation significantly enhanced the release of PGE-2 in hAFCs CM, while this increase was completely suppressed by 10 µM cxb. hAFCs revealed elevated IL-6 and IL-8 release following TNF-α and IL-1β treatment, though cxb did not alter this. The effect of hAFCs CM on DRG cell sensitization was influenced by adding cxb to hAFCs; both the DRG cell line and primary bovine DRG nociceptors showed a lower sensitivity to bradykinin stimulation.ConclusionCxb can inhibit PGE-2 production in hAFCs in an IL-1β-induced pro-inflammatory in vitro environment. The cxb applied to the hAFCs also reduces the sensitization of DRG nociceptors that are stimulated by the hAFCs CM.

Melatonin attenuated chronic visceral pain by reducing Nav1.8 expression and nociceptive neuronal sensitization.

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder, and its specific pathogenesis is still unclear. We have previously reported that TTX-resistant (TTX-R) sodium channels in colon-specific dorsal root ganglion (DRG) neurons were sensitized in a rat model of visceral hypersensitivity induced by neonatal colonic inflammation (NCI). However, the detailed molecular mechanism for activation of sodium channels remains unknown. This study was designed to examine roles for melatonin (MT) in sensitization of sodium channels in NCI rats. Colorectal distention (CRD) in adult male rats as a measure of visceral hypersensitivity. Colon-specific dorsal root ganglion (DRG) neurons were labeled with DiI and acutely dissociated for measuring excitability and sodium channel current under whole-cell patch clamp configurations. Western blot and Immunofluorescence were employed to detect changes in expression of Nav1.8 and MT2. The results showed that rats exhibited visceral hypersensitivity after NCI treatment. Intrathecal application of melatonin significantly increased the threshold of CRD in NCI rats with a dose-dependent manner, but has no role in the control group. Whole-cell patch clamp recording showed that melatonin remarkably decreased the excitability and the density of TTX-R sodium channel in DRG neurons from NCI rats. The expression of MT2 receptor at the protein level was markedly lower in NCI rats. 8MP, an agonist of MT2 receptor, enhanced the distention threshold in NCI rats. Application of 8MP reversed the enhanced hypersensitivity of DRG neurons from NCI rats. 8MP also reduced TTX-R sodium current density and modulated dynamics of TTX-R sodium current activation. These data suggest that sensitization of sodium channels of colon DRG neurons in NCI rats is most likely mediated by MT2 receptor, thus identifying a potential target for treatment for chronic visceral pain in patients with IBS.

MP03-03 TRANSCRIPTOME ANALYSIS IN LUMBOSACRAL DORSAL ROOT GANGLIA REVEALS KEY MOLECULAR CHANGES IN ANIMAL MODELS OF UROLOGICAL CHRONIC PELVIC PAIN SYNDROME (UCPPS)

You have accessJournal of UrologyCME1 Apr 2023MP03-03 TRANSCRIPTOME ANALYSIS IN LUMBOSACRAL DORSAL ROOT GANGLIA REVEALS KEY MOLECULAR CHANGES IN ANIMAL MODELS OF UROLOGICAL CHRONIC PELVIC PAIN SYNDROME (UCPPS) Sathish Kumar Yesupatham and Alison Xiaoqiao Xie Sathish Kumar YesupathamSathish Kumar Yesupatham More articles by this author and Alison Xiaoqiao XieAlison Xiaoqiao Xie More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003214.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Patients with UCPPS experience chronic pelvic pain and lower urinary tract symptoms (LUTS), such as urinary frequency, urgency, and nocturia. UCPPS symptoms are often associated with nociceptive sensitization in the peripheral and central nervous system, which underlies symptoms of bladder overactivity, pelvic pain, and centralized pain. Understanding the molecular mechanism underlying the pathogenesis of nociceptive sensitization is necessary for finding better drug targets and neuromodulation protocols to treat UCPPS symptoms. However, despite transcriptomic analysis has been conducted on the L4 & L5 dorsal root ganglia (DRGs) in injury-induced pain models, genomic analysis focusing on bladder sensory pathways have not been performed. The current study aims to characterize transcriptome changes in lumbosacral DRGs receiving bladder and pelvic sensory input in a mouse model of UCPPS. METHODS: Male and female C57BL6/J mice were used in this study. UCPPS symptoms was induced by intravesical instillations of recombinant mouse vascular endothelial growth factor (VEGFA), an animal mode of UCPPS we previously established. As a read-out of visceral hypersensitivity, Von Frey assay was performed and compared between VEGF-instilled experimental group and saline-instilled control group. Mice were sacrificed after VEGF-induced visceral hypersensitivity was observed, and their L1, L2, L6, S1 and S2 DRGs was harvested for bulk-RNA sequencing. RESULTS: Samples were sequenced at a depth of 40 million reads per sample. Data analysis was performed using Basepair Tech platform. Ingenuity pathway analysis (Qiagen) enabled to visualize the biological network changes due to UCPPS. Spliced Transcripts Alignment to a Reference (mm10) revealed changes in the Nociceptor signaling. Principal component analysis score confirms the global gene expression changes in UCPPS-like experimental group. Upstream analysis on VEGF signaling revealed activation/ inhibition of transcriptional factors like ATF3, FOSB, and BCL2. CONCLUSIONS: Our data is the first characterization on key signaling pathway changes in lumbosacral DRGs during the pathogenesis of UCPPS symptoms in animal models. VEGF and its receptors have been recognized as a urine biomarker for UCPPS in patients. Ongoing transcriptome analysis such as Ingenuity pathway analysis and Gene set enrichment analysis will further reveal the etiology of pain centric UCPPS. Source of Funding: NIDDK 25B0965/5R01DK129260-02 (Xie) © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e22 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sathish Kumar Yesupatham More articles by this author Alison Xiaoqiao Xie More articles by this author Expand All Advertisement PDF downloadLoading ...

Effect of Aerobic Exercise on IL-35 Anti-Inflammatory Cytokine and Behavioral Pain Responses in a Model of Diabetic Neuropathy Rats

Introduction: Nerve inflammation plays an important role in the occurrence and development of diabetic neuropathy pain. The aim of this study was to evaluate the effect of aerobic exercise on anti-inflammatory cytokine IL-35 and behavioral pain responses in a model of diabetic neuropathy rats.&#x0D; Methods: In this experimental study, twenty four 8-week-old male Wistar rats (weight range: 204 ± 11.3 grams) were randomly divided into three groups (n = 8): diabetic neuropathy, diabetic neuropathy exercise and control. After confirmation of diabetic neuropathy pain by hot plate behavioral tests and mechanical allodynia, the aerobic exercise protocol was implemented. IL-35 and NF-κB gene expression in spinal cord tissue was measured by real-time PCR. One-way analysis of variance and Tukey's post hoc test with SPSS version 16 software were used for statistical analysis (P &lt;0.05).&#x0D; Results: Exercise reduced the response of behavioral tests of diabetic neuropathic pain in the exercise group compared to the diabetic neuropathy group (P &lt;0.05). Induction of diabetes caused a significant decrease in IL-35 gene expression and a significant increase in NF-kB gene (P=0.001) (P=0.021).There was also a significant increase in IL-35 gene expression and a significant decrease in NF-κB gene expression in the exercise group compared to the diabetic neuropathy group (P=0.007) (P=0.034).&#x0D; Conclusion: It seems that aerobic training has reduced the sensitivity of nociceptors to pain agents by activating the anti-inflammatory cytokine IL-35 in spinal cord microglia. It is recommended to use aerobic exercise to reduce neuropathic pain.&#x0D;

Phenelzine-based probes reveal Secernin-3 is involved in thermal nociception

Chemical platforms that facilitate both the identification and elucidation of new areas for therapeutic development are necessary but lacking. Activity-based protein profiling (ABPP) leverages active site-directed chemical probes as target discovery tools that resolve activity from expression and immediately marry the targets identified with lead compounds for drug design. However, this approach has traditionally focused on predictable and intrinsic enzyme functionality. Here, we applied our activity-based proteomics discovery platform to map non-encoded and post-translationally acquired enzyme functionalities (e.g. cofactors) in vivo using chemical probes that exploit the nucleophilic hydrazine pharmacophores found in a classic antidepressant drug (e.g. phenelzine, Nardil®). We show the probes are in vivo active and can map proteome-wide tissue-specific target engagement of the drug. In addition to engaging targets (flavoenzymes monoamine oxidase A/B) that are associated with the known therapeutic mechanism as well as several other members of the flavoenzyme family, the probes captured the previously discovered N-terminal glyoxylyl (Glox) group of Secernin-3 (SCRN3) in vivo through a divergent mechanism, indicating this functional feature has biochemical activity in the brain. SCRN3 protein is ubiquitously expressed in the brain, yet gene expression is regulated by inflammatory stimuli. In an inflammatory pain mouse model, behavioral assessment of nociception showed Scrn3 male knockout mice selectively exhibited impaired thermal nociceptive sensitivity. Our study provides a guided workflow to entangle molecular (off)targets and pharmacological mechanisms for therapeutic development.

Inhibition of Nonsense-Mediated Decay Induces Nociceptive Sensitization through Activation of the Integrated Stress Response.

RNA stability is meticulously controlled. Here, we sought to determine whether an essential post-transcriptional regulatory mechanism plays a role in pain. Nonsense-mediated decay (NMD) safeguards against translation of mRNAs that harbor premature termination codons and controls the stability of ∼10% of typical protein-coding mRNAs. It hinges on the activity of the conserved kinase SMG1. Both SMG1 and its target, UPF1, are expressed in murine DRG sensory neurons. SMG1 protein is present in both the DRG and sciatic nerve. Using high-throughput sequencing, we examined changes in mRNA abundance following inhibition of SMG1. We confirmed multiple NMD stability targets in sensory neurons, including ATF4. ATF4 is preferentially translated during the integrated stress response (ISR). This led us to ask whether suspension of NMD induces the ISR. Inhibition of NMD increased eIF2-α phosphorylation and reduced the abundance of the eIF2-α phosphatase constitutive repressor of eIF2-α phosphorylation. Finally, we examined the effects of SMG1 inhibition on pain-associated behaviors. Peripheral inhibition of SMG1 results in mechanical hypersensitivity in males and females that persists for several days and priming to a subthreshold dose of PGE2. Priming was fully rescued by a small-molecule inhibitor of the ISR. Collectively, our results indicate that suspension of NMD promotes pain through stimulation of the ISR.SIGNIFICANCE STATEMENT Nociceptors undergo long-lived changes in their plasticity which may contribute to chronic pain. Translational regulation has emerged as a dominant mechanism in pain. Here, we investigate the role of a major pathway of RNA surveillance called nonsense-mediated decay (NMD). Modulation of NMD is potentially beneficial for a broad array of diseases caused by frameshift or nonsense mutations. Our results suggest that inhibition of the rate-limiting step of NMD drives behaviors associated with pain through activation of the ISR. This work reveals complex interconnectivity between RNA stability and translational regulation and suggests an important consideration in harnessing the salubrious benefits of NMD disruption.

Heterosynaptic long-term potentiation of non-nociceptive synapses requires endocannabinoids, NMDARs, CamKII, and PKCζ.

Noxious stimuli or injury can trigger long-lasting sensitization to non-nociceptive stimuli (referred to as allodynia in mammals). Long-term potentiation (LTP) of nociceptive synapses has been shown to contribute to nociceptive sensitization (hyperalgesia) and there is even evidence of heterosynaptic spread of LTP contributing to this type of sensitization. This study will focus on how activation of nociceptors elicits heterosynaptic LTP (hetLTP) in non-nociceptive synapses. Previous studies in the medicinal leech (Hirudo verbana) have demonstrated that high-frequency stimulation (HFS) of nociceptors produces both homosynaptic LTP as well as hetLTP in non-nociceptive afferent synapses. This hetLTP involves endocannabinoid-mediated disinhibition of non-nociceptive synapses at the presynaptic level, but it is not clear if there are additional processes contributing to this synaptic potentiation. In this study, we found evidence for the involvement of postsynaptic level change and observed that postsynaptic N-methyl-d-aspartate (NMDA) receptors (NMDARs) were required for this potentiation. Next, Hirudo orthologs for known LTP signaling proteins, CamKII and PKCζ, were identified based on sequences from humans, mice, and the marine mollusk Aplysia. In electrophysiological experiments, inhibitors of CamKII (AIP) and PKCζ (ZIP) were found to interfere with hetLTP. Interestingly, CamKII was found to be necessary for both induction and maintenance of hetLTP, whereas PKCζ was only necessary for maintenance. These findings show that activation of nociceptors can elicit a potentiation of non-nociceptive synapses through a process that involves both endocannabinoid-mediated disinhibition and NMDAR-initiated signaling pathways.NEW & NOTEWORTHY Pain-related sensitization involves increases in signaling by non-nociceptive sensory neurons. This can allow non-nociceptive afferents to have access to nociceptive circuitry. In this study, we examine a form of synaptic potentiation in which nociceptor activity elicits increases in non-nociceptive synapses. This process involves endocannabinoids, "gating" the activation of NMDA receptors, which in turn activate CamKII and PKCζ. This study provides an important link in how nociceptive stimuli can enhance non-nociceptive signaling related to pain.